Ovid Therapeutics (OVID) Non Operating Income (2016 - 2020)
Ovid Therapeutics' Non Operating Income came in at $590,491 for Q2 2020, up 122.8% from $264,999 a year earlier and up 123.4% from the prior quarter.
Ovid Therapeutics (OVID) Non Operating Income (2016 - 2020) Analysis & Trends
Over the trailing twelve months to Jun 30, 2020, Ovid Therapeutics reported Non Operating Income of $1.28 million, up 35.5% year-over-year; for FY2019, it was $948,224, down 0.4% from FY2018.
- Non Operating Income carries a four-year compound annual growth rate of 136.6% (FY2015 to FY2019).
- Going back by year, Non Operating Income was $952,073 in FY2018 (+372.5%), $201,509 in FY2017 (+66.8%), $120,822 in FY2016 (+299.0%) and $30,281 in FY2015.
- The Q2 2020 figure represents the highest quarterly Non Operating Income in data going back to Q1 2016.
- Year-over-year, Non Operating Income has increased for three consecutive quarters, with growth averaging 73.8% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in Q1 2018 (growth of 973.9%), and the weakest in Q3 2019 (a decline of 38.8%).
- Business Quant data shows OVID's Non Operating Income at $264,296 (Q1 2020), $299,000 (Q4 2019) and $131,000 (Q3 2019) in the three quarters before Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Ovid Therapeutics | 460.04 Mn | 92.06 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 590,491.00 |
| Mar 31, 2020 | 264,296.00 |
| Dec 31, 2019 | 299,000.00 |
| Sep 30, 2019 | 131,000.00 |
| Jun 30, 2019 | 264,999.00 |
| Mar 31, 2019 | 253,340.00 |
| Dec 31, 2018 | 216,000.00 |
| Sep 30, 2018 | 214,000.00 |
| Jun 30, 2018 | 275,000.00 |
| Mar 31, 2018 | 247,000.00 |
| Dec 31, 2017 | 88,000.00 |
| Sep 30, 2017 | 51,000.00 |
| Jun 30, 2017 | 40,000.00 |
| Mar 31, 2017 | 23,000.00 |
| Dec 31, 2016 | 27,000.00 |
| Sep 30, 2016 | 30,000.00 |
| Jun 30, 2016 | 31,000.00 |
| Mar 31, 2016 | 32,000.00 |
Ovid Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=OVID&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();